🟢 Elicio Therapeutics is trading 5.3% up today as shares rebound with Moti Investments disclosing a 6.1% stake

Elicio Therapeutics is trading 5.3% up today at $3.20. The stock is rebounding from recent selling pressure, potentially buoyed by a significant new investor.

• Moti Investments LLC disclosed a 6.1% stake in the company on July 16, 2026, signaling new institutional interest.
• This follows a dilutive $15 million registered direct offering that closed on July 6, 2026, and disappointing Phase 2 AMPLIFY-7P trial results announced on June 15, 2026.